Clinical features and mortality in COVID-19 SARI versus non COVID-19 SARI cases from Western Rajasthan, India.
Coronavirus Disease 2019
SARS-CoV2
severe acute respiratory infection
Journal
Journal of family medicine and primary care
ISSN: 2249-4863
Titre abrégé: J Family Med Prim Care
Pays: India
ID NLM: 101610082
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
02
01
2021
revised:
19
06
2021
accepted:
20
06
2021
entrez:
11
11
2021
pubmed:
12
11
2021
medline:
12
11
2021
Statut:
ppublish
Résumé
In March 2020, the Indian Council of Medical Research (ICMR) issued guidelines that all patients presenting with severe acute respiratory infections (SARI) should be investigated for coronavirus disease 2019 (COVID-19). Following the same protocol, in our institute, all patients with SARI were transferred to the COVID-19 suspect intensive care unit (ICU) and investigated for COVID-19. This study was planned to examine the demographical, clinical features, and outcomes of the first 500 suspected patients of COVID-19 with SARI admitted in the COVID-19 suspect ICU at a tertiary care center. Between March 7 and July 20, 2020, 500 patients were admitted to the COVID-19 suspect ICU. We analyzed the demographical, clinical features, and outcomes between COVID-19 positive and negative SARI cases. The records of all the patients were reviewed until July 31, 2020. Of the 500 suspected patients admitted to the hospital, 88 patients showed positive results for COVID-19 by reverse transcription-polymerase chain reaction (RT-PCR) of the nasopharyngeal swabs. The mean age in the positive group was higher (55.31 ± 16.16 years) than in the negative group (40.46 ± 17.49 years) ( In the present article, 17.6% of SARI were due to COVID-19 infection with significantly higher mortality (34.1%) in COVID-19 positive patients with SARI. Although all patients presenting as SARI have considerable mortality rates, the COVID-19-associated SARI cases thus had an almost one-third risk of mortality.
Sections du résumé
BACKGROUND
BACKGROUND
In March 2020, the Indian Council of Medical Research (ICMR) issued guidelines that all patients presenting with severe acute respiratory infections (SARI) should be investigated for coronavirus disease 2019 (COVID-19). Following the same protocol, in our institute, all patients with SARI were transferred to the COVID-19 suspect intensive care unit (ICU) and investigated for COVID-19.
METHODS
METHODS
This study was planned to examine the demographical, clinical features, and outcomes of the first 500 suspected patients of COVID-19 with SARI admitted in the COVID-19 suspect ICU at a tertiary care center. Between March 7 and July 20, 2020, 500 patients were admitted to the COVID-19 suspect ICU. We analyzed the demographical, clinical features, and outcomes between COVID-19 positive and negative SARI cases. The records of all the patients were reviewed until July 31, 2020.
RESULTS
RESULTS
Of the 500 suspected patients admitted to the hospital, 88 patients showed positive results for COVID-19 by reverse transcription-polymerase chain reaction (RT-PCR) of the nasopharyngeal swabs. The mean age in the positive group was higher (55.31 ± 16.16 years) than in the negative group (40.46 ± 17.49 years) (
CONCLUSION
CONCLUSIONS
In the present article, 17.6% of SARI were due to COVID-19 infection with significantly higher mortality (34.1%) in COVID-19 positive patients with SARI. Although all patients presenting as SARI have considerable mortality rates, the COVID-19-associated SARI cases thus had an almost one-third risk of mortality.
Identifiants
pubmed: 34760737
doi: 10.4103/jfmpc.jfmpc_14_21
pii: JFMPC-10-3240
pmc: PMC8565113
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3240-3246Informations de copyright
Copyright: © 2021 Journal of Family Medicine and Primary Care.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
J Assoc Physicians India. 2020 Jul;68(7):19-26
pubmed: 32602676
Ann Transl Med. 2020 Jun;8(11):694
pubmed: 32617314
Niger Postgrad Med J. 2020 Oct-Dec;27(4):293-301
pubmed: 33154281
J Clin Virol. 2020 Aug;129:104475
pubmed: 32485619
BMJ Evid Based Med. 2021 Jun;26(3):107-108
pubmed: 32934000
J Formos Med Assoc. 2020 May;119(5):1000-1001
pubmed: 32265095
Ann Intern Med. 2020 Aug 18;173(4):262-267
pubmed: 32422057
Int Immunopharmacol. 2020 Jul;84:106504
pubmed: 32304994
Allergy. 2021 Feb;76(2):533-550
pubmed: 32662525
Crit Care. 2020 Apr 22;24(1):167
pubmed: 32321566
Radiology. 2020 Aug;296(2):E41-E45
pubmed: 32049601
Br J Anaesth. 2021 Mar;126(3):578-589
pubmed: 33454051
Indian J Med Res. 2020 Feb & Mar;151(2 & 3):236-240
pubmed: 32362647
Am J Infect Control. 2021 Jan;49(1):82-89
pubmed: 32540370
Ann Intern Med. 2021 Jan;174(1):125-127
pubmed: 32687717
J Family Med Prim Care. 2020 Aug 25;9(8):4270-4276
pubmed: 33110844
CMAJ Open. 2021 Mar 8;9(1):E181-E188
pubmed: 33688026
Monaldi Arch Chest Dis. 2020 Jun 10;90(2):
pubmed: 32527073
Monaldi Arch Chest Dis. 2020 Apr 16;90(1):
pubmed: 32297723
J Assoc Physicians India. 2020 May;68(5):13-17
pubmed: 32610859
J Infect. 2020 Jun;80(6):666-670
pubmed: 32283165
Ann Transl Med. 2020 Mar;8(6):393
pubmed: 32355837
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
J Med Virol. 2021 Sep;93(9):5425-5431
pubmed: 33945642
Monaldi Arch Chest Dis. 2020 Apr 10;90(1):
pubmed: 32290644
Heart Lung. 2020 Nov-Dec;49(6):848-852
pubmed: 32593418
J Family Med Prim Care. 2021 Jan;10(1):542-549
pubmed: 34017785